Primas Bioscience Private Limited, a active private limited company, was established on 22 May 2019 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U36999TN2019PTC129400. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹6.50 M and a paid-up capital of ₹1.93 M.
It upholds a compliant status. Its leadership includes Prabakaran (Additional Director), Anju Chadha (Additional Director), Chandhrasekaran Kabilan (Managing Director). Past directors included Selvi. It holds ₹3.88 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A2-404, Adroit District 'S' Palandi Amman Koil Street,Thalambur, Chennai, Tamil Nadu, 600130.
U36999TN2019PTC129400
129400
22 May 2019
₹6.50 M
₹1.93 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Primas Bioscience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prabakaran | Additional Director | 19 Feb 2021 | Current |
| Anju Chadha | Additional Director | 19 Feb 2021 | Current |
| Chandhrasekaran Kabilan | Managing Director | 22 May 2019 | Current |
| Dhanraj Muthu | Director | 22 May 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Primas Bioscience Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 196.31% increase. The company also saw a substantial fall in profitability, with a 849.64% decrease in profit. The company's net worth Soared by an impressive increase of 2049.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Primas Bioscience had a public holding of 49.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹38,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2024 | Others | ₹5.00 M | Open |
| 28 Feb 2023 | Others | ₹3.38 Cr | Open |
Explore comprehensive loan charge details -
Primas Bioscience has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Primas Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Primas Bioscience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Primas Bioscience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Primas Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
A charge with Others amounted to Rs. 5.00 M with Charge ID 100870586 was registered on 31 Jan 2024. was recorded as a recent event.
A charge with Others amounted to Rs. 33.80 M with Charge ID 100683808 was registered on 28 Feb 2023. was recorded as a recent event.
The activity Prabakaran was appointed as a Additional Director was appointed as a Additional Director on 19 Feb 2021 & has been associated with this company since 4 years 10 months . was completed.
Anju Chadha was appointed as a Additional Director was appointed as a Additional Director on 19 Feb 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
The CIN of Primas Bioscience Private Limited is U36999TN2019PTC129400.
Primas Bioscience Private Limited is headquartered at A2-404, Adroit District 'S' Palandi Amman Koil Street,Thalambur, Chennai, Tamil Nadu, 600130.
Primas Bioscience Private Limited was incorporated on 22 May 2019.
The current directors of Primas Bioscience Private Limited are
The primary industry of Primas Bioscience Private Limited is Manufacturing.
Primas Bioscience Private Limited is unlisted.
The authorized capital of Primas Bioscience Private Limited is ₹6.50 M, and the paid-up capital is ₹1.93 M.
The compliance status of Primas Bioscience Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX